Odiparcil
Phase 2Completed 0 watching 0 views this week⚡ Active
47
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Mucopolysaccharidosis VI
Conditions
Mucopolysaccharidosis VI
Trial Timeline
Dec 30, 2017 → Oct 22, 2019
NCT ID
NCT03370653About Odiparcil
Odiparcil is a phase 2 stage product being developed by Inventiva for Mucopolysaccharidosis VI. The current trial status is completed. This product is registered under clinical trial identifier NCT03370653. Target conditions include Mucopolysaccharidosis VI.
Hype Score Breakdown
Clinical
17
Activity
12
Company
5
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03370653 | Phase 2 | Completed |
Competing Products
20 competing products in Mucopolysaccharidosis VI